Overcoming therapeutic resistance in driver-negative NSCLC: Immunomodulatory mechanisms and clinical efficacy of Camrelizumab-chemotherapy combination in a real-world cohort
Authors
Zhao Yang (ORCID: https://orcid.org/0000-0002-9143-671X)
Ge Yan (ORCID: https://orcid.org/0009-0001-9576-7305)
Overcoming therapeutic resistance in driver-negative NSCLC: Immunomodulatory mechanisms and clinical efficacy of Camrelizumab-chemotherapy combination in a real-world cohort
Zhao Yang, Ge Yan
Citations
1 citations
Journal
Discover Oncology
Topics
Cancer Immunotherapy and Biomarkers
Field-Weighted Citation Impact (FWCI)
1.05
article
Overcoming therapeutic resistance in driver-negative NSCLC: Immunomodulatory mechanisms and clinical efficacy of Camrelizumab-chemotherapy combination in a real-world cohort
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Overcoming therapeutic resistance in driver-negative NSCLC: Immunomodulatory mechanisms and clinical efficacy of Camrelizumab-chemotherapy combination in a real-world cohort — Zhao Yang, Ge Yan · Discover Oncology (2025) | TGRS Research Map | TGRS